Wellington Management Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Wellington Management Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49,544	Closed	-$924K	–	2250
2022 Q1	$924K	Buy	49,544 +23,420	+90%	+$421K	﹤0.01%	1751
2021 Q4	$559K	Buy	+26,124	New	+$515K	﹤0.01%	1949
2021 Q3	–	Sell	-22,919	Closed	-$491K	–	2320
2021 Q2	$491K	Buy	+22,919	New	+$466K	﹤0.01%	1925

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wellington Management Group's OCDX Position: Q2 2022 in Review

Wellington Management Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 49,544 shares — an estimated $924K sold.

Wellington Management Group first reported a position in OCDX in Q2 2021 and held it in 3 quarters. The position peaked at $924K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Wellington Management Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Wellington Management Group sold 49,544 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $924K.
Wellington Management Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
Wellington Management Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $924K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.